Bob Mauch's leadership at Cencora focuses on digital transformation, talent development, and growth-oriented investments to ...
Novo Nordisk will hold an Extraordinary General Meeting to elect new board members due to a disagreement with the Foundation ...
Sanofi's Tzield gains FDA's expedited review, promising rapid access to innovative treatment for type 1 diabetes and ...
The MFN pricing approach, while politically attractive, raises complex questions about how to fairly and sustainably price ...
Galapagos announced plans to scale back on its cell therapy business, while the company pursues new transformational business ...
In light of the recent Congressional Budget Office report highlighting the impact of lower National Institutes of Health ...
Peptilogics Founder and CEO, Jonathan Steckbeck noted that advances in peptide design and safety have positioned the field to ...
The adoption of artificial intelligence (AI) has accelerated, yet its impact on R&D productivity remains underwhelming.
Pharmaceutical Executive: What impact will TrumpRx and other DTC programs have on drug availability? Jesse Mendelsohn: To be ...
Frontier Scientific Solutions, a contract service organization (CSO), and Air Transport Services Group, a provider of ...
In today’s Pharmaceutical Executive Daily, we cover the FDA’s creation of a new National Priority Voucher Program, the market ...
Amid converging pharma pricing trends, such as those triggered by the Inflation Reduction Act, companies must adopt novel operational practices and strategic approaches in line with new parameters for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback